RxDoctor Payments Data

Kristina Utzschneider

Endocrinology, Diabetes & Metabolism · Seattle, WANPI 1932219805

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $66,825 of the $72,467 with a category attached, or 92.2%. Avid Radiopharmaceuticals, Inc. accounts for 75.9% of it on its own, with 3 other manufacturers making up the rest. 2023 is the largest year on record at $57,825, more than ten times the $1,028 reported in 2019. Among endocrinology, diabetes & metabolism clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,467in general payments, 2019–2025

Across 48 payments — averaging $1509.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avid Radiopharmaceuticals, Inc.$55K
  • Nevro Corp.$13K
  • Eli Lilly$3K
  • Medtronic$1K
$411,954in research payments, 2019–2025

Across 21 payments — averaging $19,617 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$266K
  • Avid Radiopharmaceuticals, Inc.$110K
  • Amgen$36K

What the payments were for

  • Consulting fees$66,82592%
  • Travel & lodging$5,2907%
  • Food & beverage$3520%

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Avid Radiopharmaceuticals, Inc.2$55,025
Nevro Corp.17$13,170
Eli Lilly15$3,244
Medtronic14$1,028

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,467 in reported general payments places this provider in the 95th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.

See all endocrinology, diabetes & metabolism providers in Washington

Other endocrinology, diabetes & metabolism in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →